copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Reshma Kewalramani - Wikipedia Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020 [1][2][3] She is the first female CEO of a large US biotech company [2]
Reshma Kewalramani | CEO and President at Vertex Pharmaceuticals Reshma Kewalramani is the CEO and President of Vertex Pharmaceuticals A highly experienced medical doctor, clinician, researcher and nephrologist, she is well equipped to lead Vertex to its next stage of growth
Vertex Pharmaceuticals CEO and Key Executive Team - Craft Vertex Pharmaceuticals's Chief Executive Officer, President Director is Reshma Kewalramani Vertex Pharmaceuticals's key executives include Reshma Kewalramani and 19 others
President CEO at Vertex Pharmaceuticals - The Org Reshma Kewalramani, M D , FASN, is the President and Chief Executive Officer at Vertex Dr Kewalramani has dedicated her career to improving the lives of patients, including the last 15+ years through the development of new medicines
Reshma Kewalramani | Fortune Reshma Kewalramani, who brings her experience as a licensed doctor to her leadership, took the helm as CEO of Vertex Pharmaceuticals in 2020, having previously served as the biopharma company’s
About Vertex Pharmaceuticals About Vertex Pharmaceuticals Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people living with serious diseases, with a focus on specialty markets
Reshma Kewalramani, CEO of Vertex Pharmaceuticals Reshma Kewalramani is the CEO of Vertex Pharmaceuticals, having taken on the role in April 2020 after previously serving as the Chief Medical Officer She has made significant impacts in the biotech industry, particularly known for her work on medicines that treat cystic fibrosis